Amedisys Home Health | |
4161 Tamiami Trl Bldg 8 Unit 801 A, Port Charlotte, Florida 33952 | |
(941) 629-1600 | |
Name | Amedisys Home Health |
---|---|
Location | 4161 Tamiami Trl Bldg 8 Unit 801 A, Port Charlotte, Florida |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 108270 |
Ownership Type | Proprietary |
Service Area Zip Codes | 33901, 33903, 33904, 33905, 33907, 33908, 33909, 33912, 33913, 33914, 33916, 33917, 33919, 33920, 33921, 33922, 33928, 33931, 33935, 33936, 33946, 33947, 33948, 33950, 33952, 33953, 33954, 33955, 33956, 33966, 33967, 33971, 33972, 33973, 33974, 33976, 33980, 33981, 33982, 33983, 33990, 33991, 33993, 34102, 34103, 34104, 34105, 34108, 34109, 34110, 34112, 34113, 34114, 34116, 34117, 34119, 34120, 34134, 34135, 34142, 34145, 34223, 34224, 34228, 34229, 34231, 34232, 34233, 34234, 34235, 34236, 34237, 34238, 34239, 34240, 34241, 34242, 34243, 34266, 34267, 34269, 34275, 34285, 34286, 34287, 34288, 34289, 34291, 34292, 34293 |
NPI Number | 1043392038 |
Organization Name | INFINITY HOME CARE OF PORT CHARLOTTE, LLC |
Doing Business As | AMEDISYS HOME HEALTH |
Address | 4161 Tamiami Trail, Building 8, Unit 801a, Port Charlotte, FL 33952 |
Phone Number | 941-629-1600 |
News Archive
TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.
Merz Pharmaceuticals today announced that Xeomin (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010.
Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.
Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.
An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria - the energy-producing factory of the cell - and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.
› Verified 7 days ago
NPI Number | 1922067230 |
Organization Name | SUN COAST HOME CARE SERVICES, INC. |
Address | 3508 Tamiami Trl, Suite A, Port Charlotte, FL 33952 |
Phone Number | 941-629-1600 |
News Archive
TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.
Merz Pharmaceuticals today announced that Xeomin (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010.
Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.
Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.
An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria - the energy-producing factory of the cell - and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.
› Verified 7 days ago
NPI Number | 1972810695 |
Organization Name | HOUSECALL HOME HEALTH, LLC |
Doing Business As | AMEDISYS HOME HEALTH |
Address | 2765 Tamiami Trl, Port Charlotte, FL 33952 |
Phone Number | 941-625-5502 |
News Archive
TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.
Merz Pharmaceuticals today announced that Xeomin (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010.
Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.
Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.
An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria - the energy-producing factory of the cell - and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.
› Verified 7 days ago
Quality Rating: |
News Archive
TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.
Merz Pharmaceuticals today announced that Xeomin (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010.
Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.
Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.
An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria - the energy-producing factory of the cell - and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.6 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
How often the home health team checked patients for depression | 86.2 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 83.8 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 84 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.3 | 96.4 |
News Archive
TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.
Merz Pharmaceuticals today announced that Xeomin (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010.
Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.
Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.
An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria - the energy-producing factory of the cell - and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 85.6 | 79.6 |
How often patients got better at getting in and out of bed | 86.4 | 81.1 |
How often patients got better at bathing | 90.8 | 82.3 |
How often patients’ breathing improved | 91.3 | 82.8 |
How often patients’ wounds improved or healed after an operation | 94.5 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 85.8 | 75 |
How often home health patients had to be admitted to the hospital | 14.9 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.6 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 98 | 94 |
News Archive
TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.
Merz Pharmaceuticals today announced that Xeomin (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010.
Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.
Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.
An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria - the energy-producing factory of the cell - and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.
Merz Pharmaceuticals today announced that Xeomin (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010.
Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.
Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.
An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria - the energy-producing factory of the cell - and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.
› Verified 7 days ago
The patient survey data of Amedisys Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 83 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 87 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 82 | 78 |
News Archive
TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.
Merz Pharmaceuticals today announced that Xeomin (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010.
Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.
Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.
An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria - the energy-producing factory of the cell - and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.
› Verified 7 days ago
Mederi Caretenders Location: 18501 Murdock Circle Suite 602, Port Charlotte, Florida 33948 Ratings: Phone: (941) 379-0801 | |
Kindred At Home Location: 970 Kings Highway Ste 2, Port Charlotte, Florida 33980 Ratings: Phone: (239) 277-1003 | |
Sunrise Home Health & Supplies Llc Location: 22110 Kimble Ave, Port Charlotte, Florida 33952 Ratings: Phone: (941) 235-1722 | |
Amedisys Home Health Location: 4161 Tamiami Trl Bldg 8 Unit 801 A, Port Charlotte, Florida 33952 Ratings: Phone: (941) 629-1600 | |
Signature Homenow Location: 3417 Tamiami Trail Suite A, Port Charlotte, Florida 33952 Ratings: Phone: (941) 629-1212 | |
Millennium Home Care Llc Location: 1500 Kings Highway, Port Charlotte, Florida 33980 Ratings: Phone: (855) 674-7500 |